Search Results for 'formulation'

Contract Service Directory Companies

View All Buyers Guide Companies »

Contract Service Directory Categories

View All Categories »

• Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
  

  Enteris BioPharma: Custom Solutions – From Bench to Market

  CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

  ---

• Clinical Trial Materials | Drug Development | Formulation Development
  

  On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture

  Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.

  ---

• Breaking News | cGMP Manufacture | Formulation Development | Industry News
  

  Piramal Pharma Solutions, Plus Therapeutics Ink MSA 


  Piramal to perform services related to the development, manufacture, and supply of Plus Therapeutics’ RNL-Liposome Intermediate Drug Product.

  Kristin Brooks 03.24.21
  

  ---

• Breaking News | Formulation Development | Industry News
  

  Cybin to Leverage Catalent’s Zydis for Psychiatric Drug

  To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders.

  Kristin Brooks 03.22.21
  

  ---

• Breaking News | Formulation Development | Industry News
  

  Rentschler, Leukocare Extend Service Offering with U.S. Site

  Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.

  Kristin Brooks 03.22.21
  

  ---

• Drug Delivery | Formulation Development
  

  On Demand Webinar - Formulation Strategies for Poorly Soluble Molecules

  Pharmaceutics and Biopharmaceutics Considerations - Now Available to Watch On Demand

  ---

• APIs | Formulation Development
  

  Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

  Travis Webb, Formulation Scientist at CoreRx, will discuss the use of in vitro flux and permeability as a tool in formulation dev in this March 30 webinar.

  02.24.21
  

  ---

• APIs | Drug Delivery
  

  Screening Permeability as a Tool in Formulation Selection

  Improving bioavailability can be crucial to creating a dosage form that is easy to use and meets requirements for patient compliance.

  ---

• APIs | Breaking News | Formulation Development | Industry News
  

  Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

  Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.

  Kristin Brooks 02.22.21
  

  ---

• 2nd Annual Analytical Characterisation and Formulation

  ...

  02.17.21
  

  ---

• Breaking News | Formulation Development | Industry News | Promotions & Moves
  

  Novartis Vet Joins CDMO Sai Life Sciences

  Mahavir Prashad named as vice president of early phase process development.

  Tim Wright, Editor, Contract Pharma 02.17.21
  

  ---

• APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
  

  Lonza Expands Solid Small Molecule Services

  To encompass all aspects of solid form screening and characterization of small molecule APIs.

  Kristin Brooks 02.16.21
  

  ---

• Breaking News | Formulation Development | Industry News | Methods Development
  

  Adare Pharma Solutions Opens New Small-Scale Lab

  Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.

  Kristin Brooks 01.26.21
  

  ---

• Formulation Development
  

  Coating Place Wurster Fluid Bed Process Scaling

  With a 45-year history of involvement in formulation dev and application, this design strategy lends significant ease and predictability to process scale-up.

  ---

• Breaking News | Formulation Development | Industry News
  

  Hovione Launches ASD-HIPROS

  Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.

  Contract Pharma Staff 01.12.21
  

  ---

• 

  Formulation Development

  Innovate | Integrate | Customize | Accelerate

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Parenterals
  

  Irisys Receives NIH Contract for the Formulation of Drinabant

  Seeks to develop a drug for treatment of acute cannabinoid overdose.

  Contract Pharma Staff 01.11.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
  

  Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

  Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.

  Contract Pharma Staff 01.04.21
  

  ---

• 

  RTP Formulation & Sterile Fill-Finish Facility

  ...

  Videos

  ---

• Formulation Development
  

  Formulation of Monodisperse Controlled-Release Quetiapine Microspheres

  Adare’s Optimμm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.

  ---

• Breaking News | Drug Development | Formulation Development | Industry News
  

  Vectura, Kinaset Partner to Develop Asthma Treatment

  Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.

  Contract Pharma Staff 11.30.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
  

  Lonza Expands Development, Mfg. Capabilities at Bend Site

  Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.

  Contract Pharma Staff 11.30.20
  

  ---

• Formulation Development
  

  **ADVERTORIAL** Advanced Formulation Development by Design in the Context of Holistic Drug Production

  A strong trend in drug substance and drug product biomanufacturing, as is for formulation, is that of increasing therapeutic complexity.

  Latika Bhonsle-Deeng, Rentschler Biopharma SE, and Konstantin Petropoulos, LEUKOCARE AG 10.14.20
  

  ---

• Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
  

  Cambrex Completes Edinburgh Expansion

  Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.

  Contract Pharma Staff 10.12.20
  

  ---

• Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
  

  Catalent Launches OneXpress Solution

  Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.

  Contract Pharma Staff 10.01.20
  

  ---

• Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
  

  Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

  Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.

  Contract Pharma Staff 09.30.20
  

  ---

• APIs | Formulation Development
  

  Premature Release from Wurster Fluid Bed Enteric Coatings

  The Wurster (bottom spray) fluid bed coating process provides an optimal means to apply enteric coatings on API or API containing particles.

  ---

• APIs | Formulation Development
  

  Expanding Solutions for Challenging APIs Through Coacervation

  Download Adare Pharma Solutions' whitepaper to learn how the coacervation method can help solve your formulation challenges.

  ---

• APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
  

  Piramal to Deliver Integrated Services to Epirium

  Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.

  Contract Pharma Staff 08.27.20
  

  ---

• Breaking News | Collaborations & Alliances | Formulation Development
  

  TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

  Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.

  Contract Pharma Staff 08.17.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
  

  Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

  Dalton to provide formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early phase clinical trials.

  Contract Pharma Staff 07.28.20
  

  ---

• Breaking News | Promotions & Moves
  

  Avomeen Appoints Formulation, Manufacturing Head

  Hashim Ahmed brings more than 25 years of experience from the biopharmaceutical and CDMO industries.

  Contract Pharma Staff 07.16.20
  

  ---

• Breaking News | Drug Development | Formulation Development | Industry News | Laboratory Testing | Methods Development
  

  MilliporeSigma Opens M Lab Collaboration Center in Shanghai

  Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.

  Contract Pharma Staff 07.10.20
  

  ---

• Breaking News | Collaborations & Alliances | Formulation Development
  

  Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler

  Enerzair Breezhaler uses Vectura’s formulation IP, and is a first-in-class fixed-dose combination maintenance treatment for uncontrolled asthma.

  Contract Pharma Staff 07.07.20
  

  ---

• 

  Free Webinar: Developing an Oral Modified Release (MR) Formulation

  Challenges and Considerations for Achieving Success

  ---

• Formulation Development | Industry News
  

  SeraNovo, Carna Biosciences Enter Second License Agreement

  To develop an oral formulation of a new active ingredient with enhanced bioavailability.

  Contract Pharma Staff 05.26.20
  

  ---

• Formulation Development | Industry News | Trials & Filings
  

  Triphase, Catalent Announce Interim TRPH-222 Results in NHL

  TRPH-222 leverages Catalent’s SMARTag platform to provide optimized site-specific protein-modification and linker technologies.

  Contract Pharma Staff 05.19.20
  

  ---

• Advances in Drug Formulation & Delivery

  ...

  05.13.20
  

  ---

• Bioprocessing Summit: Formulation, Stability & Aggregation

  ...

  05.13.20
  

  ---

• Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
  

  Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact

  Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a repurposed antiviral drug for the potential treatment of COVID-19

  Contract Pharma Staff 05.13.20
  

  ---

• Breaking News | Formulation Development | Industry News
  

  Adare Pharma Acquires Orbis Biosciences

  Expands Adare’s technology platforms and product development capabilities.

  Contract Pharma Staff 05.05.20
  

  ---

• Breaking News | cGMP Manufacture | Fill/Finish | Industry News
  

  Catalent Completes $14M Biologics Packaging Expansion

  Adds 15,000 square feet of packaging infrastructure to biologics and sterile manufacturing at its Bloomington, IN facility

  Contract Pharma Staff 04.23.20
  

  ---

• Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Injectables
  

  Micropore, InnoCore Enter Injectable Drugs Collaboration

  Will deploy encapsulation technology in the production of a new generation of long acting injectables

  Contract Pharma Staff 04.21.20
  

  ---

• Breaking News | Collaborations & Alliances | Industry News
  

  Evotec, leon-nanodrugs Enter Nanomedicine Pact

  Evotec makes strategic investment in leon by leading the company's Series B funding round

  Contract Pharma Staff 04.17.20
  

  ---

• Breaking News | Industry News
  

  MedPharm Helps Fight COVID-19 Outbreak

  Donates hand sanitizer for healthcare providers and other essential workers

  Contract Pharma Staff 04.15.20
  

  ---

• Bio News | Breaking News | Industry News
  

  Theravance Responds to COVID-19 Pandemic

  Advances TD-0903 to treat hospitalized patients with acute lung injury

  Contract Pharma Staff 04.13.20
  

  ---

• Drug Development | Industry News
  

  Leading BioSciences Drug May Help Critical COVID-19 Patients

  Investigational drug, LB1148, being considered to treat respiratory distress and organ dysfunction in critically ill COVID-19 patients

  04.08.20
  

  ---

• Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer
  

  Rapid Delivery of Medical Countermeasures Amid Pandemic

  Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines

  Online Exclusives Kristin Brooks, Contract Pharma 04.03.20
  

  ---

• Drug Delivery
  

  CEO Spotlight: Will Downie

  Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMO

  Tim Wright, Editor, Contract Pharma 04.01.20
  

  ---

• Biologics, Proteins, Vaccines
  

  The Evolution of the ADC Manufacturer

  How CMDOs can rise to the occasion

  Lisa McDermott and Jyothi Swamy, MilliporeSigma 04.01.20
  

  ---